Temporomandibular Dysfunction in Patients With Diabetic Foot Ulcers

Sponsor
Harran University (Other)
Overall Status
Completed
CT.gov ID
NCT06067022
Collaborator
(none)
84
1
5.9
14.1

Study Details

Study Description

Brief Summary

The aim of this observational study is to investigate the effects of the type, area and duration of ulceration on jaw pain, mandibular function limitation, TMD and swallowing in individuals with diabetic foot ulcers.The main questions it aims to answer are:

  • Does the change in foot structure due to diabetic foot ulcer have an effect on the temporomandibular jointand swalloving?

  • What are the determinants of tempomandibular dysfunction in individuals with diabetic foot ulcers?

Participants (both groups) will be evaluated for quality of life, jaw functionality, mandibular dysfunction, oropharyngeal swallowing disorder, pain and diabetes complications.

Condition or Disease Intervention/Treatment Phase
  • Other: observation

Detailed Description

The study was planned in an observational case-control study design. 84 participants were included. Individuals who signed the Informed Consent Form were included in the study. Individuals aged between 46-80 (min-max) who were diagnosed with type 2 DM and DFU in Harran University Research and Application Hospital Endocrinology Polyclinic were included in the study group, and healthy individuals aged 37-85 (min-max) without a diagnosis of DM were included in the control group. Among the exclusion criteria for all individuals from the study, the Mini-Mental Test score should be below 24, history of psychiatric illness, cancer, neurological problems, congenital anomalies, musculoskeletal problems, having a systemic disease, facial paralysis, undergoing surgery due to spine, abdomen and/or TMJ problem and receiving any treatment related to the spine and TMJ in less than 6 months.

In the clinical evaluation of individuals with DFU about diabetes and ulcers; diabetes duration, HbA1C value, glycemic control adequacy, and peripheral arterial disease were recorded, monofilament test was performed for sensory evaluation. Ulcer type and duration were recorded, and ulcer area was measured. Individuals' quality of life was evaluated with the Ferran Powers Quality of Life Index. In the evaluation of oral health in all participants; burning mouth syndrome, dry mouth sensation, tooth loss, tooth decay, and intraoral lesions were questioned.

Participants' pain reports were evaluated using the Numerical Rating Scale (NRS).

Participants' swallowing disorders were evaluated using the Eating Assessment Tool (EAT-10).

Participants' TMJ disorders were evaluated using the Fonseca Anamnestic Index.

Participants' mandibular dysfunctions were evaluated using the Mandibular Function Disorder Questionnaire .

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
84 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Temporomandibular Dysfunction in Patients With Diabetic Foot Ulcers: What Could Be the Predictors?
Actual Study Start Date :
Jan 5, 2023
Actual Primary Completion Date :
Jun 5, 2023
Actual Study Completion Date :
Jul 5, 2023

Arms and Interventions

Arm Intervention/Treatment
Study Group

42 patients with diabetic foot ulcers were included. For patients in this group, regarding diabetic foot; Sensory assessment, ulcer area and depth measurement, and diabetes management information were measured. Apart from these evaluations, quality of life, pain, mandibular function and oropharyngeal swallowing problems were evaluated.

Other: observation
Planned measurements and scales will be applied

Control Group

42 patients without diabetes were included. Patients in this group were evaluated for general health and quality of life, pain, mandibular function and oropharyngeal swallowing problems.

Other: observation
Planned measurements and scales will be applied

Outcome Measures

Primary Outcome Measures

  1. Temporomandibular Dysfunction [baseline]

    An umbrella term covering pain and dysfunction of the muscles of mastication (the muscles that move the jaw) and the temporomandibular joints (the joints which connect the mandible to the skull). Temporomandibular Dysfunction was assessed using the Mandibular Function Disorder Questionnaire. This valid and reliable scale evaluating mandibular dysfunction consists of two dimensions and 17 questions. The first 11 items form the Functional Capacity dimension, and the next six items form the Nutrition dimension. Each question is scored from '0' (no difficulty) to '4' (very difficult or impossible without assistance). A high total score obtained from the questionnaire indicates a high level of impairment in jaw function.

Secondary Outcome Measures

  1. Quality of life assessment [baseline]

    Quality of life is an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. The participants' quality of life was evaluated using the Ferrans&Powers Quality of Life Index Diabetes Version.The Quality of Life Assessment Index consists of two parts and a total of 68 items. In the first part, in 6-point Likert order (1=not at all satisfied, 6=very satisfied) the patient's satisfaction/pleasure in various areas of life; In the second part (1=not at all important, 6=very important) the importance levels of various life areas of the patient are questioned. It is scored in the categories of health and functional capacity, socioeconomic status, psychological belief status, family status, and total quality of life. A high score indicates a good quality of life.

  2. Swallowing Disorders [baseline]

    Swallowing disorders (Dysphagia) is the medical term for swallowing difficulties. Some people with dysphagia have problems swallowing certain foods or liquids, while others can't swallow at all. Participants' swallowing disorders were evaluated using the Eating Assessment Tool (EAT-10). The scale, which evaluates the symptoms and severity of oropharyngeal swallowing disorder and is valid and reliable, consists of 10 questions. Each question is scored between '0' (no problem) and '4' (serious problem). A total score of 3 and above on the scale between 0-40 indicates a swallowing problem.

  3. Pain assessment [baseline]

    Participants' pain reports were evaluated using the Numerical Rating Scale (NRS). It is a simple, valid, and reliable method that is frequently used in measuring the severity of pain in the clinic. The participant is asked to mark a number on a 10 cm scale, on which numbers are shown in the range of "0" (no pain) to "10" (unbearable pain) for the pain he feels in the TMJ region

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being over 18 years old

  • Having been diagnosed with Type 2 diabetes for at least 10 years

  • Not having a serious musculoskeletal, cardiac, neurological, etc. systemic disorder that may interfere with the research.

  • Not having any communication problems

Exclusion Criteria:
  • Having a diabetic foot ulcer

  • Having a diagnosed psychiatric disease,

  • Having had a temporomandibular joint operation,

  • Having experienced direct or indirect trauma to the head-neck and spine area,

  • Having had previous spine surgery,

  • Having any mental problems,

  • Having a neuromuscular problem that proves a systemic specific pathological condition such as malignant condition of the spine and/or TMJ, fracture, rheumatoid disease,

  • Having had facial paralysis less than 1 year ago,

  • Being diagnosed with TMD,

  • Having received TMJ-related physical therapy treatment in less than 6 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fatih Enzin Sanliurfa Haliliye Turkey 63200

Sponsors and Collaborators

  • Harran University

Investigators

  • Principal Investigator: Fatih Enzin, asst prof dr, Harran University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fatih Enzin, assistant professor, Harran University
ClinicalTrials.gov Identifier:
NCT06067022
Other Study ID Numbers:
  • fatihenzin
First Posted:
Oct 4, 2023
Last Update Posted:
Oct 4, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fatih Enzin, assistant professor, Harran University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 4, 2023